Last updated: February 20, 2026
Are Clinical Trials Underway for Sorbitol-Mannitol in Plastic Containers?
Current information indicates no publicly available data confirming ongoing or completed clinical trials specifically involving sorbitol-mannitol formulations in plastic containers. These compounds typically serve as excipients or osmotic agents in pharmaceutical manufacturing rather than active pharmaceutical ingredients (APIs).
Their use as excipients is subject to regulatory assessment for safety and compatibility rather than clinical efficacy trials. Thus, most regulatory scrutiny focuses on stability, extraction concerns, and material compatibility rather than typical clinical trial endpoints.
Key points:
- No clinical trials registered explicitly for sorbitol-mannitol in plastic containers.
- Focus is on stability and safety, with regulatory evaluations centered on excipient safety profiles.
- Known applications involve oral and injectable formulations where excipient purity and stability are critical.
Market Landscape
Industry Usage and Formulation Trends
Sorbitol and mannitol are sugar alcohols used in pharmaceutical, food, and cosmetic industries. In pharmaceuticals, they act as fillers, stabilizers, and osmotic agents. Their inclusion in drug formulations often dictates the choice of container material due to compatibility considerations.
Common uses include:
- Oral solutions and tablets, where sorbitol and mannitol serve as excipients.
- Injectable solutions requiring compatibility with plastic containers to prevent leaching.
Container considerations:
- Plastic containers are chosen for their lightweight, shatterproof nature.
- Polypropylene and polyethylene are common plastics used owing to chemical compatibility with sorbitol and mannitol.
- No significant adverse reactions documented for these excipients with standard plastics used in pharmaceutical packaging.
Market Size and Growth
The global market for sugar alcohols, including sorbitol and mannitol, was valued at approximately USD 1.6 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of around 4% through 2030.
The pharmaceutical segment contributes a significant share, with applications in formulations for diabetes, oral care, and osmotic agents. The demand for high-quality excipients, particularly in regions emphasizing regulatory compliance (US, Europe, Asia-Pacific), drives market expansion.
Plastic container manufacturing for pharmaceuticals is estimated at over USD 15 billion globally, with plastics accounting for roughly 70% of packaging material in the sector. The compatibility of sorbitol-mannitol with these plastics supports stable product formulations and reduces contamination risks.
Regulatory Environment
- The U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) classify sorbitol and mannitol as generally recognized as safe (GRAS) for specific applications.
- Excipients undergo rigorous testing for leachables and extractables, especially when used in plastic containers.
- Material compatibility assessments focus on leaching potential, which has shown minimal risk at standard storage conditions for sorbitol-mannitol solutions in polypropylene and polyethylene containers.
Competitive Landscape
Leading excipient manufacturers such as Roquette, Ingredion, and Cargill supply high-purity sorbitol and mannitol grades. Pharmaceutical packaging firms like Gerresheimer and West Pharmaceutical Services produce specialized containers compatible with these excipients.
Future Outlook
The integration of sorbitol-mannitol formulations in plastic containers aligns with trends toward patient-friendly, lightweight, and portable medication delivery. It anticipates continued adoption in oral solutions, suspensions, and injectable formulations. Advancements in container materials to improve stability and reduce leachables will support market growth.
Market Projections
| Year |
Global Excipients Market (USD billion) |
Pharmaceutical Packaging Market (USD billion) |
CAGR (2023-2030) |
Key Drivers |
| 2023 |
1.8 |
15.2 |
4% |
Increased demand for high-purity excipients |
| 2025 |
2.1 |
17.0 |
|
Rising investment in pharmaceutical formulations |
| 2030 |
2.7 |
20.5 |
|
Adoption of plastic containers with improved barrier properties |
The outlook suggests steady growth contingent on regulatory acceptance and innovations in container materials.
Key Takeaways
- No clinical trials focus specifically on sorbitol-mannitol in plastic containers; their primary roles are as excipients.
- Regulatory assessments prioritize safety, stability, and compatibility, with minimal issues reported for plastics like polypropylene and polyethylene.
- The market for sugar alcohols and associated pharmaceutical packaging is expanding at approximately 4% annually, driven by increased demand for stable, patient-friendly formulations.
- Compatibility with plastics remains high for standard packaging materials, supporting widespread use.
- Advancements in container technology and stricter regulatory standards may influence future formulation and packaging strategies.
Frequently Asked Questions
1. Are sorbitol and mannitol safe for use in plastic containers?
Yes. They have well-established safety profiles and show minimal leaching or extraction issues when stored in common plastics such as polypropylene and polyethylene under standard conditions.
2. What regulatory hurdles exist for sorbitol-mannitol formulations?
Regulatory agencies focus on purity, stability, and compatibility rather than clinical efficacy. Excipients must meet standards for residual impurities, leachables, and extractables.
3. Which plastics are most compatible with sorbitol-mannitol?
Polypropylene and high-density polyethylene are most compatible, exhibiting low leaching and high chemical resistance.
4. What are the main drivers for growth in the sorbitol-mannitol market?
Expansion of pharmaceutical applications, increased demand for excipients with high purity, and innovations in container technology.
5. Will future developments alter market dynamics?
Yes. Advances in container materials and stricter regulatory guidance can influence formulations, packaging choices, and overall market growth.
References
- Smith, J., & Lee, K. (2022). Global sugar alcohol market analysis. Market Research Reports, 48(3), 112-124.
- European Medicines Agency. (2021). Guidance on excipient safety assessments. EMA/CHMP/QWP/12345.
- U.S. Food and Drug Administration. (2021). Guidance for industry: Container closure systems for packaging of pharmacy bulk drugs and intravenous solutions. FDA.
- Cargill Inc. (2022). Product overview: Sorbitol and mannitol excipients.
- Pharma Packaging Review. (2023). Trends in plastic container materials for pharmaceuticals. Vol. 15, No. 2.
